News

CEO of company that created Ozempic and Wegovy addressed 'long-term' impacts of the drug
Lars Fruergaard Jørgensen, the boss of Danish pharmaceutical giant Novo Nordisk, explained what impact the drugs can have on users weight in the long run ...
‘There's a huge percentage of the US population that isn't getting access to these medications’: Novo Nordisk makes game-changing $2 billion deal for new obesity d…
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
Gastroenterology Advisor22h
Novo Nordisk Partners With Telehealth Platforms to Expand Wegovy Access
Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy.
Zacks Investment Research on MSN23h
Pharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline Update
Novo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...